Centaur Pharmaceuticals Private Limited — Metformin Exporter Profile
Indian Pharmaceutical Exporter · #13 for Metformin · $7.1M export value · DGFT Verified
Centaur Pharmaceuticals Private Limited is the #13 Indian exporter of Metformin with $7.1M in export value and 173 verified shipments. Centaur Pharmaceuticals Private Limited holds a 1.5% market share in Metformin exports across 5 countries. The company exports 6 pharmaceutical products worth $11.1M across 4 therapeutic categories.
Centaur Pharmaceuticals Private Limited — Metformin Export Profile: Buyers & Destinations
Where Does Centaur Pharmaceuticals Private Limited Export Metformin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $8.9M | 226 | 77.4% |
| UNITED KINGDOM | $1.9M | 118 | 16.7% |
| SOUTH AFRICA | $658.5K | 17 | 5.8% |
| SRI LANKA | $10.5K | 2 | 0.1% |
| SINGAPORE | $7.9K | 1 | 0.1% |
| FRANCE | $237 | 1 | 0.0% |
| ITALY | $13 | 53 | 0.0% |
Centaur Pharmaceuticals Private Limited exports Metformin to 7 countries. The largest destination is GERMANY accounting for 77.4% of Centaur Pharmaceuticals Private Limited's Metformin shipments, followed by UNITED KINGDOM (16.7%) and SOUTH AFRICA (5.8%). These destinations reflect Centaur Pharmaceuticals Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Metformin from Centaur Pharmaceuticals Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MERCKLE GMBH | GERMANY | $4.1M | 112 |
| BERLIN-CHEMIE AG. | GERMANY | $2.5M | 65 |
| WOCKHARDT UK LIMITED | UNITED KINGDOM | $1.8M | 114 |
| BERLIN-CHEMIE AG | GERMANY | $1.5M | 34 |
| BERLIN CHEMIE AG | GERMANY | $666.6K | 15 |
| TEVA PHARMACEUTICALS (PTY) LTD. | SOUTH AFRICA | $560.7K | 15 |
| TEVA PHARMACEUTICALS PTY LIMITED | SOUTH AFRICA | $97.7K | 2 |
| WOCKHARDT UK LIMITED. | UNITED KINGDOM | $71.7K | 4 |
| GEORGE STEUART HEALTH (PVT) LTD | SRI LANKA | $10.5K | 2 |
| TEVA PHARMACEUTICAL INVESTMENTS SIN | SINGAPORE | $7.9K | 1 |
Centaur Pharmaceuticals Private Limited supplies Metformin to 16 buyers globally. The largest buyer is MERCKLE GMBH (GERMANY), followed by BERLIN-CHEMIE AG. (GERMANY) and WOCKHARDT UK LIMITED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Metformin Export Value and How Much Does Centaur Pharmaceuticals Private Limited Contribute?
India exported $266.5M worth of Metformin through 15,000 shipments from 528 suppliers to 160 countries, serving 1,475 buyers globally. Centaur Pharmaceuticals Private Limited contributes $7.1M to this total, accounting for 1.5% of India's Metformin exports. Centaur Pharmaceuticals Private Limited ships Metformin to 7 countries through 16 buyers.
What Is the Average Shipment Value for Centaur Pharmaceuticals Private Limited's Metformin Exports?
Centaur Pharmaceuticals Private Limited's average Metformin shipment value is $40.9K per consignment, based on 173 shipments totaling $7.1M. The largest destination is GERMANY (77.4% of Centaur Pharmaceuticals Private Limited's Metformin exports).
How Does Centaur Pharmaceuticals Private Limited Compare to Other Indian Metformin Exporters?
Centaur Pharmaceuticals Private Limited ranks #13 among 528 Indian Metformin exporters with a 1.5% market share. The top 3 exporters are GRANULES INDIA LIMITED ($113.9M), ZENTIVA PRIVATE LIMITED ($19.4M), IPCA LABORATORIES LIMITED ($17.1M). Centaur Pharmaceuticals Private Limited processed 173 shipments to 5 destination countries.
What Metformin Formulations Does Centaur Pharmaceuticals Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| INDIAN HARMLESS MEDICINES - METFORMIN HY | $2.0M | 49 |
| METFORMAX SR 750MG / METFORMIN HYDROCHLO | $339.5K | 8 |
| INDIAN HARMLESS MEDICINES - METFORMIN HYDROCHLORIDE EXTENDED RELEASE TABLETS 1000MG ARTICLE NO-Z143674 | $320.9K | 10 |
| METFORMIN TEVA ER 1000 MG / METFORMIN HY | $273.1K | 6 |
| INDIAN HARMLESS MEDICINES - METFORMIN HYDROCHLORIDE EXTENDED RELEASE TABLETS 750MG ARTICLE NO-Z143673 | $260.2K | 6 |
| METFORMAX SR 1000MG / METFORMIN HYDROCHL | $230.5K | 5 |
| INDIAN HARMLESS MEDICINES METFORMIN HYDROCHLORIDE EXTENDED RELEASE TABLETS 500MG 1 TABLET EACH EXTENDED RELEASE TABLE | $226.6K | 5 |
| METFORMAX SR 1000MG/METFORMIN HYDROCHLOR | $205.2K | 5 |
| METFORMAX SR 1000MG / METFORMIN HYDROCHLORIDE EXTENDED RELEASE TABLETS 1000 MG -6X10'S - PL EACH TABLET CONTAINS: METFO | $203.2K | 5 |
| METFORMIN TEVA XR 1000 MG / METFORMIN HY | $195.7K | 5 |
Centaur Pharmaceuticals Private Limited exports 171 distinct Metformin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is INDIAN HARMLESS MEDICINES - METFORMIN HY with 49 shipments worth $2.0M.
Regulatory Requirements: Exporting Metformin to Key Markets
What Centaur Pharmaceuticals Private Limited must comply with to export Metformin to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Centaur Pharmaceuticals Private Limited Compare to Nearest Metformin Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | ZYDUS LIFESCIENCES LIMITED | $9.8M | 196 | 8 | $50.0K |
| 10 | USV PRIVATE LIMITED | $9.2M | 240 | 7 | $38.3K |
| 13 | CENTAUR PHARMACEUTICALS PRIVATE LIMITED ★ | $7.1M | 173 | 5 | $40.9K |
| 14 | AUROBINDO PHARMA LIMITED | $7.0M | 251 | 9 | $27.9K |
| 15 | HARMAN FINOCHEM LIMITED | $6.9M | 295 | 6 | $23.4K |
Centaur Pharmaceuticals Private Limited ranks #13 among 528 Indian Metformin exporters. Average shipment value of $40.9K compared to the market average of $504.7K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and USV PRIVATE LIMITED.
Which Indian Ports Ship Metformin Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 2,284 | 15.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,638 | 10.9% |
| HYDERABAD ICD (INSNF6) | 1,593 | 10.6% |
| DELHI AIR CARGO ACC (INDEL4) | 1,355 | 9.0% |
| SAHAR AIR | 1,015 | 6.8% |
| JNPT/ NHAVA SHEVA SEA | 843 | 5.6% |
| DELHI AIR | 711 | 4.7% |
| Bombay Air | 695 | 4.6% |
Geopolitical & Trade Policy Impact on Centaur Pharmaceuticals Private Limited's Metformin Exports
Centaur's export operations are currently navigating a complex geopolitical landscape. The ongoing Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to alter trade routes. This has resulted in extended transit times and elevated freight rates, impacting the cost-effectiveness and timeliness of pharmaceutical exports from India to Europe. (livemint.com) For Centaur, which relies heavily on these shipping lanes, such disruptions necessitate strategic adjustments in logistics and supply chain management.
In the United States, the push for pharmaceutical manufacturing reshoring and the imposition of tariffs on imported drugs have introduced additional challenges for Indian exporters. Centaur's acquisition of Bayshore Pharmaceuticals LLC can be seen as a strategic response to these developments, enabling the company to establish a local presence and potentially circumvent some of the trade barriers. (prysm.fi) This move reflects a proactive approach to maintaining competitiveness in a rapidly evolving market.
Furthermore, compliance with the European Union's falsified medicines directive requires stringent adherence to quality and safety standards. For Centaur, ensuring compliance with these regulations is crucial to sustaining and expanding its market share in the EU. The company's commitment to quality is evident in its successful USFDA audits and adherence to Good Manufacturing Practices (GMP). (moneycontrol.com)
Centaur Pharmaceuticals Private Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for Centaur's export operations. The company has demonstrated a strong commitment to quality, as evidenced by its Pune finished dosage facility completing a USFDA audit with zero Form 483 observations, resulting in a No Action Indicated (NAI) compliance status. (moneycontrol.com) This achievement underscores Centaur's adherence to current Good Manufacturing Practices (cGMP) and its dedication to producing high-quality pharmaceutical products.
However, the evolving regulatory landscape, including the EU's falsified medicines directive and the US's emphasis on domestic manufacturing, necessitates continuous vigilance and adaptation. Centaur's proactive measures, such as acquiring U.S.-based entities and ensuring compliance with international standards, position the company to navigate these challenges effectively.
About Centaur Pharmaceuticals Private Limited
Centaur Pharmaceuticals Private Limited exports 6 products worth $11.1M. Beyond Metformin, top products include Gliclazide, Clonazepam, Alprazolam, Lorazepam, Tetracycline. View the complete Centaur Pharmaceuticals Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Metformin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Metformin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Centaur Pharmaceuticals Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 418 individual customs records matching Centaur Pharmaceuticals Private Limited exporting Metformin, covering 171 formulations to 7 countries via 16 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 160+ countries, 1,475+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Metformin Export Data from Centaur Pharmaceuticals Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Centaur Pharmaceuticals Private Limited's Metformin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Centaur Pharmaceuticals Private Limited
Full Company Profile →
6 products · $11.1M total trade · 4 categories
Metformin Stats
Company Overview
Top Products by Centaur Pharmaceuticals Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Centaur Pharmaceuticals Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Metformin. For current shipment-level data, contact TransData Nexus.